GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹146 Cr | ₹137 Cr | - | - | - |
What is the latest Long Term Provisions ratio of GLAND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹146 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Long Term Provisions of GLAND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹146 Cr | 6.40 | |
| Mar2024 | ₹137 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Long Term Provisions of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹42,091.5 Cr | 3.6% | 12.3% | 34.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3.6% |
12.3% |
34.4% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses